The reason cola is being regulated is not branding. It is the underlying science. Decades of peer-reviewed work — and consolidated guidance from the World Health Organization — have linked routine consumption of sugar-sweetened beverages (SSBs) to elevated risk of metabolic disease, dental harm, and excess mortality. The exact effect sizes vary by study and population, but the direction is consistent across the literature.
1 — Metabolic disease
Habitual SSB intake is associated with weight gain, insulin resistance, and elevated risk of type 2 diabetes — independent of total caloric intake in many studies. The mechanistic story (rapid glucose load, fructose-driven hepatic lipogenesis, weak satiety response from liquid sugar) is well characterized.
2 — Cardiometabolic risk
Long-running cohort studies link SSB consumption to higher rates of cardiovascular events and unfavorable lipid profiles. This is one reason health authorities treat SSBs as analogous to tobacco and alcohol in policy framing — not in toxicity, but in the population-level burden of routine consumption.
3 — Dental and pediatric harm
The dental case is among the strongest in nutrition epidemiology: routine SSB intake is causally linked to dental caries, especially in children. Pediatric exposure also shapes lifelong taste preferences and consumption defaults — a reason most national guidelines now recommend water and milk for young children.
4 — All-cause mortality
Several large prospective cohorts have found small but statistically meaningful associations between high SSB consumption and all-cause mortality, persisting after adjustment for BMI, diet quality, and physical activity.
Diagram · Mechanism of harm
- 1
Intake
Liquid sugar, ~39g per 12oz cola
- 2
Glycemic load
Rapid blood-glucose & insulin spike
- 3
Hepatic processing
Fructose → de novo lipogenesis
- 4
Satiety
Liquid calories suppress fullness signaling
- 5
Repeated exposure
Insulin resistance, weight gain, dyslipidemia
- 6
Population effect
↑ T2D, CVD, dental caries, all-cause mortality
Diagram
Plain-language flow from a single SSB serving to population-level disease burden, summarizing the mechanistic chain most commonly cited in nutrition epidemiology.
Methodology
Editorial synthesis of the dominant mechanistic story across consensus reviews and WHO guidance. Each step in the flow is itself an active area of research; the diagram is intended as an at-a-glance map, not a clinical claim.
Figure
Order-of-magnitude relative-risk increases associated with high vs low sugar-sweetened beverage intake across four endpoints: type 2 diabetes, cardiovascular disease, dental caries, and all-cause mortality.
Methodology
Values are rounded directional summaries of effect sizes routinely reported across cohort studies and meta-analyses. Effect sizes vary by population, exposure definition, and adjustment set; readers needing exact figures should consult the linked primary literature.
5 — Why this drives policy
When a single SKU is associated with even modest population-level increases in chronic disease, the math gets large fast. That is the case the WHO is making for 50% health taxes, the case the German government cited in announcing its 2028 levy (Reuters), and the case underwriting US SNAP eligibility changes in Texas (Texas HHS).